BioLineRx : Reports First Quarter 2024 Financial Results and Recent Corporate and Portfolio Updates
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER ...
Source: marketscreener.com
Philipa Serlin News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Philipa Serlin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Philipa Serlin Today - Breaking & Trending Today
BioLineRx : Announces Poster Presentation on Economic Model Data for APHEXDA® (motixafortide) as part of CD34+ Hematopoietic Stem Cell Mobilization in Patients with Multiple Myeloma at ISPOR 2024
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER ...
Source: marketscreener.com
BioLineRx : Form 20-F/A (Amendment No. 1 -March 28, 2024 at 05:36 am EDT
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A ...
Source: marketscreener.com
BioLineRx : Report of Periodic or Interim Report -March 26, 2024 at 08:26 am EDT
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE...
Source: marketscreener.com
BioLineRx : Annual Report on Form 20-F FOR 2023 -March 26, 2024 at 08:40 am EDT
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ...
Source: marketscreener.com